US reg­u­la­tors have ex­tend­ed their re­view of Novo's he­mo­phil­ia A in­jec­tion denec­imig be­cause of is­sues at an un­named man­u­fac­tur­ing fa­cil­i­ty.

The FDA at­trib­uted the de­lay...

Sen­si­ble Biotech­nolo­gies is look­ing to mark its ter­ri­to­ry in the in­creas­ing­ly hot space of mR­NA ther­a­peu­tics, rais­ing $47 mil­lion in a Se­ries A round to...

Plus news about ADC Ther­a­peu­tics, Atri­um Ther­a­peu­tics, Bris­tol My­ers, No­var­tis and Pfiz­er.

Bio­haven part­ners with Ono: Tokyo-based Ono Phar­ma­ceu­ti­cal has agreedto pay Bio­haven $80...

A Dutch court has or­dered Mer­ck to stop man­u­fac­tur­ing and sell­ing its in­jectable for­mu­la­tion of Keytru­da in eight Eu­ro­pean coun­tries.

The court ruled that Mer­ck...

Bay­er on Fri­day laid out its vi­sion for a $2.2 bil­lion man­u­fac­tur­ing site in Ohio that would cre­ate about 600 new jobs in the area...